Furthermore, mice with a combined deletion of Tet2 and Tet3 in B cells (using CD19-Cre) rapidly developed DLBCL-like tumors from germinal center B cells with complete penetrance and a median survival of ~20 weeks [125]. The gene discussed is CD19; the disease is diffuse large B-cell lymphoma.